Editing Food and Drug Administration (section)

===Medical countermeasures (MCMs)===
{{Further|Biosecurity|Bioterrorism|Biosecurity in the United States}}
Medical countermeasures (MCMs) are products such as [[biologics]] and [[pharmaceutical drug]]s that can protect from or treat the health effects of a chemical, biological, radiological, or nuclear (CBRN) attack. MCMs can also be used for prevention and diagnosis of symptoms associated with CBRN attacks or threats.<ref name="fdamcm">{{cite web |title=What are Medical Countermeasures? |url=https://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm431268.htm | publisher = U.S. Food and Drug Administ ration: Emergency Preparedness and Response |access-date=June 15, 2016 |archive-date=April 22, 2019 |archive-url=https://web.archive.org/web/20190422171542/https://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm431268.htm |url-status=live}}</ref> The FDA runs a program called the "FDA Medical Countermeasures Initiative" (MCMi), with programs funded by the federal government. It helps support "partner" agencies and organisations prepare for [[Public health emergency (United States)|public health emergencies]] that could require MCMs.<ref name="fdamcm" /><ref>{{cite news |title=Alliance for Biosecurity applauds subcommittee efforts to sustain medical countermeasure funding |url=https://homelandprepnews.com/biological-threats/bioterrorism/18984-alliance-biosecurity-applauds-subcommittee-efforts-sustain-medical-countermeasure-funding/ |access-date=June 15, 2016 |work=Homeland Preparedness News |date=June 8, 2016 |location=Washington, D.C. |archive-date=January 28, 2021 |archive-url=https://web.archive.org/web/20210128183519/https://homelandprepnews.com/stories/18984-alliance-biosecurity-applauds-subcommittee-efforts-sustain-medical-countermeasure-funding/ |url-status=live}}</ref>